Exploring the role of polyploidy in tumor progression

NIH RePORTER · NIH · F31 · $20,418 · view on reporter.nih.gov ↗

Abstract

Recent genomic analysis of human cancer sequencing data estimates over one third of human tumors undergo whole-genome duplication events. While applications of sequencing technology have revealed the prevalence of polyploidy in human cancer, the functional implications of polyploidy in cancer remain poorly defined. I propose to experimentally assess the effects of polyploidy on tumor progression using a murine model of breast cancer tumorigenesis. First, I will determine how polyploidy affects primary tumor growth. I will then determine if polyploidy influences the genetic alterations selected for in primary tumors. Finally, I will assess the consequences of polyploidy with respect to disease recurrence. I hypothesize that polyploidy promotes tumor growth in the context of primary tumor formation and recurrence, while uniquely shaping the genetic alterations present in tumors. Understanding how whole-genome duplication events affect tumor progression will provide important insight into the functional implications of polyploidy in cancer, and will yield a better understanding of events that shape the cancer genome.

Key facts

NIH application ID
10104461
Project number
5F31CA239421-03
Recipient
DUKE UNIVERSITY
Principal Investigator
Rachel Leanne Newcomb
Activity code
F31
Funding institute
NIH
Fiscal year
2021
Award amount
$20,418
Award type
5
Project period
2019-04-01 → 2021-08-31